DNMT3AR882H Is Not Required for Disease Maintenance in Primary Human AML, but Is Associated With Increased Leukemia Stem Cell Frequency
Thomas Köhnke(California Institute for Regenerative Medicine), Ravindra Majeti(Stanford University), Kensuke Kayamori(California Institute for Regenerative Medicine), Jonas L. Fowler(California Institute for Regenerative Medicine), Daiki Karigane(Keio University), Eleanor Hilgart(Johns Hopkins University), Amy C. Fan(Stanford University), Yang Feng(University of Florida), Fabian P. Suchy(California Institute for Regenerative Medicine), Michael A. Koldobskiy(Johns Hopkins University), Andrew P. Feinberg(Johns Hopkins University), Eduardo Martínez‐Montes(Johns Hopkins University), Yusuke Nakauchi(Stanford University), Athreya Rangavajhula(California Institute for Regenerative Medicine), Masashi Miyauchi(California Institute for Regenerative Medicine), Cailin Collins(California Institute for Regenerative Medicine), Hiromitsu Nakauchi(Tokyo Medical and Dental University), Kyle M. Loh(California Institute for Regenerative Medicine)
Cited by 3
Related Papers
Epigenetic memory in induced pluripotent stem cells
|Nature|2010|2.3k
Epigenome-wide association data implicate DNA methylation as an intermediary of genetic risk in rheumatoid arthritis
|Nature Biotechnology|2013|1k
First-in-Human, First-in-Class Phase I Trial of the Anti-CD47 Antibody Hu5F9-G4 in Patients With Advanced Cancers
|Journal of Clinical Oncology|2019|590
Disrupting the CD47-SIRPα anti-phagocytic axis by a humanized anti-CD47 antibody is an efficacious treatment for malignant pediatric brain tumors
|Science Translational Medicine|2017|427
A Src-Like Inactive Conformation in the Abl Tyrosine Kinase Domain
|PLoS Biology|2006|322